Pros | ![]() 5Y returns in the top 25% of the category. ![]() 3Y returns in the top 25% of the category. ![]() Beats FD returns for both 3Y & 5Y duration. | ![]() Larger AUM within category. ![]() Beats FD returns for both 3Y & 5Y duration. | ||
Cons | - | ![]() 5Y returns in the bottom 25% of the category. |
INDMoney rank | 2/8 | 7/8 | ||
Category,Subcateogry | Equity,Sector - Healthcare | Equity,Sector - Healthcare | ||
Fund Age | 12 Years | 12 Years | ||
Fund Size | 3963 Cr | 8357 Cr | ||
Min Investment | SIP ₹500 Lumpsum ₹5000 | SIP ₹100 Lumpsum ₹5000 | ||
Expense Ratio | 0.91% | 0.89% | ||
Exit Load | 0.5% | 1% | ||
Benchmark Index | BSE Healthcare TR INR | BSE Healthcare TR INR |
No of Holdings | 34 | 41 | ||
Top 5 Holdings | Sun Pharmaceuticals Industries Ltd (10.86%) Divi's Laboratories Ltd (6.81%) Max Healthcare Institute Ltd Ordinary Shares (6.12%) Cipla Ltd (4.81%) Lonza Group Ltd ADR (4.24%) | Sun Pharmaceuticals Industries Ltd (11.94%) Divi's Laboratories Ltd (7.34%) Cipla Ltd (6.09%) Lupin Ltd (6.09%) Apollo Hospitals Enterprise Ltd (5.91%) | ||
No of Sectors | 3 | 1 | ||
Top 3 Sectors | Health (93.98%) Basic Materials (6.02%) Government (1.7%) | Health (100%) | ||
Equity % | 96.15% | 99.48% | ||
Debt % | - | - | ||
P/E | 44.11 | 36.11 | ||
P/B | 6.33 | 5.78 | ||
Credit Quality | - | - | ||
Modified Duration | - | - | ||
YTM | - | - |
1-Month Return | 0.57% | -0.41% | ||
3-Month Return | 2.13% | 0.84% | ||
6-Month Return | 10.73% | 11.92% | ||
1-Year Return | 4.11% | -1.2% | ||
3-Year Return | 27.28% | 24.31% | ||
5-Year Return | 21.63% | 19.51% |
Sharpe | 1.36 | 1.06 | ||
Alpha | 4.73 | 0.66 | ||
Beta | 0.84 | 0.91 | ||
Standard Deviation | 13.92 | 15.05 | ||
Information Ratio | 0.72 | -0.24 |
Description | SBI Healthcare Opportunities Fund Direct Growth is an equity fund.The fund could potentially beat inflation in the long-run. | Nippon India Pharma Fund - Direct Plan - Growth Plan is an equity fund.The fund could potentially beat inflation in the long-run. | ||
Managers | Tanmaya Desai | Sailesh Raj Bhan,Kinjal Desai |